patients in the walking test, so that disability cannot be accurately predicted from these simple measurements of pulmonary function. The walking test is a self paced measurement of exercise capacity and so may be influenced by factors other than pulmonary function, especially the attitudes and motivation of the patient, and these subjective factors have been shown to outweigh the FEV, and the FVC as predictors and determinants of performance in walking
in the step test were significantly greater than in either the cycle or the walking test. No patient was able to reach and sustain steady state values of VE and Vo2 in the step test, whereas a steady state for both VE and Vo2 was reached and sustained by all eight patients in the walking test. It is suggested that at least three practice attempts at any exercise test should be made before the introduction of either placebo or specific pharmacological treatment and that even then it may be necessary to allow for the effects of further repeated testing in the assessment of the results of treatment.
A large component of the morbidity of chronic obstructive lung disease results from exertional breathlessness and restriction of physical activity. The 12 minute walking test' was introduced in an attempt to quantify the effects of disease on exercise capacity and has subsequently become widely used. It has become apparent that there is, at best, only a weak' and sometimes no2 relationship between the sevenity of airflow obstruction (assessed by the FEV, and the forced vital capacity-FVC) and the performance of patients in the walking test, so that disability cannot be accurately predicted from these simple measurements of pulmonary function. The walking test is a self paced measurement of exercise capacity and so may be influenced by factors other than pulmonary function, especially the attitudes and motivation of the patient, and these subjective factors have been shown to outweigh the FEV, and the FVC as predictors and determinants of performance in walking tests.34 In addition, walking is a familiar form of exercise and the observation that the distance walked in 12 minutes (12 MWD) can be accurately predicted from the distance walked in two or six minutes5 suggests that patients select from experi-582 able to sustain without undue discomfort. This suggestion is supported by the observation that encouragement given to patients during the walking test significantly and substantially improves their performance in this test. 6 The 12 MWD has been shown to improve during the first three measurements in the short term2 and may in the longer term require many more attempts before a peak distance is reached.7 Both "learning" and specific training are probably involved in this improvement, which may in addition depend on the pattern and frequency of testing. The This test was also performed by age and sex matched normal controls with no symptomatic evidence of lung disease. In this control group there were five men and five women per decade over the range 45-75 years.
CYCLE ERGOMETER TEST
The tests were performed on an electrically braked cycle ergometer (Lanooy). Heart rate was recorded with an electrocardiogram. A noseclip was worn and expired gas was collected via a mouthpiece and 115 ml dead space two way valve (Hans Rudolf Type 2700). Ventilation (VE) and oxygen consumption (Vo2) were measured every 20 seconds with commercially available computerised equipment incorporating a rolling seal spirometer and dynamic mixing of the expired gas (Gould 9000 IV). Exercise was preceded by a four minute rest period. The ergometer was set running at 50-60 rev/min by an investigator, so that the patients did not have to overcome the inertia of the machine. The work rate was increased by 10 watts every minute and started at a setting of 10 watts. The patients were instructed to maintain a pedal frequency of 50-60 rev/min and to continue pedalling until they indicated their desire to stop.
PROTOCOL
The patients were admitted to hospital. No change was made to their usual treatment. Spirometric values were recorded daily at 9.00 am one hour after inhalation of salbutamol (200 ,ug). The highest value from three attempts was recorded. On days when exercise performance was tested all three forms of exercise assessment were conducted. At least one hour was allowed to elapse between tests, which were performed at similar times of day in the same sequence. Exercise tests were performed on the first three consecutive days during the admission with no change in treatment and were repeated after three daily doses of placebo tablets. We do not know how closely these patients approached their true physiological maximum exercise capacity in these tests, but the measurements of ventilation and oxygen consumption during exercise may provide some indication. The highest ventilation and oxygen consumption were reached during the step test, in which none of the patients so tested achieved a steady state for ventilation or oxygen consumption, and consequently none sustained the peak levels of ventilation or oxygen consumption that they reached, unlike the normal age and sex matched controls. By contrast, while walking the patients all achieved steady state values for ventilation and oxygen consumption within six minutes, which they were then able to sustain for the remainder of the test. The peak values for ventilation and oxygen consumption while walking were on average 12% and 15% respectively, lower than while step- ping. This suggests that the patients selected from experience a walking speed just below the maximum level of ventilation and oxygen consumption which they were able to sustain without undue discomfort or fatigue.
An important observation is the continuing improvement in exercise performance clearly seen in all three types of test with repeated testing. This is unlikely to have been due to physical training over such a short period, but it was not surprising in symptom limited tests such as these because increasing familiarity with the tests may have led to an increase in confidence and therefore motivation. The trend for improvement between successive tests became progressively smaller with repeated testing and was no longer significant between the third and fourth attempts, the latter being performed after three days of placebo. We were therefore unable to identify any significant effect of placebo drug on exercise performance that was distinct from the placebo effects of repeated testing. If 
